Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 283
Filter
1.
HU rev ; 48: 1-8, 2022.
Article in Portuguese | LILACS | ID: biblio-1371594

ABSTRACT

Introdução: O Brasil, assim como outros países, vem alterando seu perfil demográfico elevando o número de pessoas idosas, o que repercute em mudanças não só para sociedade, mas também para saúde pública. Este grupo de pacientes é mais vulnerável devido à fisiologia inerente ao envelhecimento, logo se tornam mais propensos ao uso de medicamentos que podem causar outros problemas de saúde. Essa probabilidade de risco é uma preocupação atual e levou a criação de métodos que norteiam os prescritores para adequarem suas terapêuticas neste grupo de pacientes. Um destes métodos é o critério de Beers, que é atualizado periodicamente trazendo uma lista de medicamentos potencialmente inapropriados (MPIs) para idosos. Objetivo: Avaliar a prescrição de pacientes idosos internados no Hospital Universitário da Universidade Federal de Juiz de Fora (HU-UFJF/Ebserh) quanto à prevalência do uso de MPI e polifarmácia, no período de julho a agosto de 2019. Material e Métodos: Estudo observacional descritivo e retrospectivo, cujos dados foram coletados de prontuários pacientes idosos com idade igual ou superior a 65 anos para obtenção dos resultados que foram avaliados estatisticamente. Resultados: Foram avaliados 187 prontuários, e observada prevalência de 80,2% da prescrição de MPIs, sendo os mais prevalentes omeprazol e benzodiazepínicos. A maioria dos pacientes tiveram polifarmácia (95,7%). Conclusão: Os resultados convergem com base no critério de Beers, para necessidade de adequar a terapia de pacientes idosos. É necessário também avaliar os benefícios e alternativas quanto aos MPIs mais prevalentes, além de realizar estudos observacionais sobre possíveis efeitos adversos que possam ser consequência do uso desses medicamentos, com objetivo de aperfeiçoar a terapia farmacológica e aprimorar a farmacoeconomia, melhorando assim a qualidade de vida dos pacientes idosos.


Introduction: Brazil, like other countries, has been changing its demographic profile, increasing the number of elderly people, which reflects in changes not only for society, but also for public health. This group of patients is more vulnerable due to the inherent physiology of aging, so they become more likely to use medications that can cause other health problems. This risk probability is a current concern and has led to the creation of methods that guide prescribers to adapt their therapies in this group of patients. One of these methods is the Beers criterion, which is periodically updated with a list of potentially inappropriate medications (PIM) for the elderly. Objective: To evaluate the prescription of elderly patients hospitalized at the University Hospital of Juiz de Fora (HU-UFJF/Ebserh) regarding the prevalence of the use of PIM and polypharmacy, from July to August 2019. Material and Methods: Descriptive and retrospective observational study, whose data were collected from medical records of elderly patients aged 65 years or older to obtain the results that were statistically evaluated. Results: A total of 187 medical records were evaluated, and a prevalence of 80.2% of the prescription of PIMs was observed, the most prevalent being omeprazol and benzodiazepines. Most patients had polypharmacy (95.7%). Conclusion: The results converge, based on the Beers criterion, for the need to suit the therapy of elderly patients. It is also necessary to evaluate the benefits and alternatives regarding the most prevalent PIMs, in addition to conducting observational studies on possible adverse effects that may be a consequence of the use of these medications, aiming to refine pharmacological therapy and improve pharmacoeconomics, thus improving quality of life of elderly patients.


Subject(s)
Drug Prescriptions , Aging , Health of the Elderly , Polypharmacy , Drug Evaluation , Drug Therapy , Drug-Related Side Effects and Adverse Reactions , Drug Utilization , Potentially Inappropriate Medication List , Hospitalization
2.
Rev. Hosp. Ital. B. Aires (2004) ; 41(4): 180-185, dic. 2021. ilus, tab
Article in Spanish | LILACS, BINACIS, UNISALUD | ID: biblio-1366880

ABSTRACT

El síndrome de intolerancia a múltiples medicamentos (MDIS, por sus siglas en inglés) se caracteriza por la intolerancia a dos o más medicamentos no relacionados. Tiene una prevalencia baja y es común en pacientes con polifarmacia. A pesar de que las reacciones adversas a los medicamentos son muy frecuentes, es raro que los pacientes debuten con este síndrome, el cual tiene implicaciones clínicas de leves a graves que afectan su vida; de acuerdo con esto varían el abordaje y su manejo. La sintomatología presentada varía desde síntomas gastrointestinales como reflujo gastroesofágico, dolores musculares y cefalea, hasta síntomas cutáneos; estos son los más frecuentes, tales como urticaria y erupciones maculopapulares o presentaciones menos comunes como el síndrome de Stevens-Johnson. El MDIS es causado por una amplia variedad de fármacos; por ello el conocimiento del síndrome, así como un adecuado interrogatorio de los antecedentes del paciente, es necesario para realizar un diagnóstico oportuno e instaurar un manejo adecuado y preventivo, evitando reacciones adversas que pongan en riesgo su vida. Con los hallazgos del cuadro clínico en la paciente, y basados en los antecedentes alérgicos presentados anteriormente a diferentes medicamentos no relacionados entre ellos, más la presentación de un rash maculopapular generalizado posterior a la administración de trimetoprim/sulfametoxazol se realiza el diagnóstico de MDIS. Se decide cambiar de medicamento por fosfomicina, con una consecuente evolución favorable. (AU)


Subject(s)
Humans , Female , Adult , Drug Eruptions/diagnosis , Drug Hypersensitivity Syndrome/diagnosis , Drug Hypersensitivity Syndrome/physiopathology , Trimethoprim, Sulfamethoxazole Drug Combination/adverse effects , Loratadine/administration & dosage , Polypharmacy , Fosfomycin/administration & dosage
4.
Rev. psiquiatr. Urug ; 85(1): 28-42, oct. 2021. graf, tab
Article in Spanish | LILACS, BNUY, UY-BNMED | ID: biblio-1343130

ABSTRACT

El tratamiento farmacológico de demostrada eficacia en la esquizofrenia es el antipsicótico. Sin embargo, en muchas ocasiones se requiere medicación concomitante que depende de comorbilidades y efectos adversos. Se realizó un estudio cuantitativo, longitudinal, retrospectivo, considerando el año 2006 y 2016, en una población de usuarios con esquizofrenia de la Policlínica del Hospital Vilardebó, analizando los tratamientos con psicofármacos. Se diferenciaron los tratamientos según monoterapia antipsicótica y polifarmacia con 2 antipsicóticos, y polifarmacia con más de 2 antipsicóticos, antidepresivos, estabilizantes del humor, benzodiacepinas y anticolinérgicos. La población inicial en 2006 fue de 621 pacientes y 398 pacientes continuaban en tratamiento en 2016. Mantuvieron el trata-miento con antipsicóticos 377 pacientes; 184 mantuvieron benzodiacepinas; 59 se mantuvieron con anticolinérgicos; 49, con estabilizantes del humor y 47, con antidepresivos. La monoterapia antipsicótica se presentó en torno al 50 % de la población estudiada. Se deberían revisar aquellas prácticas que se infieren a partir de este estudio, como el uso prolongado de anticolinérgicos, benzodiacepinas, y polifarmacia con más de 2 antipsicóticos, que está extendida en los usuarios con esquizofrenia. El tratamiento con clozapina fue el más estable y no parece aumentar la mortalidad en estos pacientes


Antipsychotics are the proved effective therapy for schizophrenia. However, on many occasions, associated drugs are required depending on comorbidities and side effects. A retrospective longitudinal quantitative study of drug prescription for 2006 and 2016 in patients with schizophrenia diagnosis was carried out in an outpatient clinic at Hospital Vilardebó. Treatments were classified as antipsychotic monotherapy, two antipsychotic drugs polypharmacy and polypharmacy with two antipsychotic drugs, antidepressants, mood stabilizers, benzodiazepines and anticholinergic drugs. Initial population in 2006 included 621 patients, 398 were still being treated in 2016. Antipsychotic drugs were still being received in 377 patients, benzodiazepines in 184, anticholinergic drugs in 59, mood stabilizers in 49, and anti-depressants in 47. Antipsychotic monotherapy was 50% of the population. Those practices that can be inferred from this study, with lengthy use of anticholinergic drugs, benzodiazepines, and the use of more than 2 antipsychotic drugs in patients with schizophrenia diagnosis should be revised. Clozapine therapy was the most stable and does not seem to increase mortality.


Subject(s)
Humans , Male , Female , Adult , Middle Aged , Aged , Schizophrenia/drug therapy , Antipsychotic Agents/therapeutic use , Drug Therapy/statistics & numerical data , Phenothiazines/therapeutic use , Chlorpromazine/therapeutic use , Epidemiology, Descriptive , Retrospective Studies , Cohort Studies , Clozapine/therapeutic use , Risperidone/therapeutic use , Polypharmacy , Age and Sex Distribution , Tiapride Hydrochloride/therapeutic use , Quetiapine Fumarate/therapeutic use , Aripiprazole/therapeutic use , Olanzapine/therapeutic use , Haloperidol/therapeutic use , Methotrimeprazine/therapeutic use
5.
Rev. habanera cienc. méd ; 20(3): e3643, tab
Article in Spanish | LILACS, CUMED | ID: biblio-1280440

ABSTRACT

Introducción: Revisar la prescripción representa una oportunidad para corregir errores y optimizar la farmacoterapia en grupos vulnerables. Objetivos: Analizar la complejidad farmacoterapéutica que se presenta en el paciente polimedicado del medio residencial. Material y Métodos: Estudio descriptivo, retrospectivo y transversal; de esquema terapéutico con elementos de indicación-prescripción. Universo: 117 historias clínicas de pacientes polimedicados con 60 años y más que residen en los hogares de ancianos. Período: junio-julio del 2020. Escenario: todos los hogares de ancianos en Cienfuegos, Cuba. Variable dependiente: complejidad farmacoterapéutica definida por la presencia de tres o más de los indicadores de calidad de vida medidos por la evaluación geriátrica exhaustiva, Escala de Puntuación Acumulativa de Enfermedad en Geriatría y criterios STOPP/START. Variables independientes: edad, sexo, enfermedad relacionada al mayor consumo de medicamentos, validismo, comorbilidad, tipo de prescripción, medicamentos inadecuados. Fuente: historia clínica individual. Resultados: La complejidad farmacoterapéutica en los polimedicados se detectó en el 76,9 por ciento de los prescritos inadecuadamente, con multimorbilidad (OR=17,3; IC95 por ciento:16-18,6), dependientes funcionales (OR=9,9; IC95 por ciento:6,8-13) y ancianos ≥75 años (OR=5,1; IC95 por ciento:4-6,2). Las benzodiacepinas fue el grupo más prescrito inadecuadamente. Los antiagregantes plaquetarios y las estatinas son los medicamentos indicados no prescritos. Conclusiones: Los ancianos polimedicados del medio residencial tienen prescripciones de grupos/fármacos de uso frecuente que se relacionan con errores de prescripción, que expone polifarmacia inadecuada y complejidad farmacoterapéutica con posible amenaza a la calidad de vida del geronte institucionalizado(AU)


Introduction: Reviewing the prescription represents an opportunity to correct errors and to optimize pharmacotherapy in vulnerable groups. Objectives: To analyze the pharmacotherapeutic complexity that occurs in the polymedicated patients living in the residential environment. Material and Methods: Descriptive, retrospective and cross-sectional study of therapeutic scheme with indication-prescription elements. Universe: 117 medical records of polymedicated patients aged 60 years and over who reside in nursing homes. Period: June-July 2020. Scenario: all nursing homes in Cienfuegos, Cuba. Dependent variable: pharmacotherapeutic complexity defined by the presence of three or more indicators of the quality of life measured by the exhaustive geriatric assessment, the Cumulative Illness Rating Scale for Geriatrics (CIRS-G) and the STOPP/START criteria. Independent variables: age, sex, disease related to increased drug use, validity, comorbidity, type of prescription, inappropriate medications. Source: individual medical history. Results: Pharmacotherapeutic complexity in polymedicated elderly was identified in 76.9 percent of those inappropriately prescribed, multimorbid (OR = 17.3; 95 percent CI: 16-18.6), functionally dependent (OR = 9.9; 95 percent: 6.8 -13) and elderly people ≥75 years (OR = 5.1; 95 percent CI: 4-6.2). Benzodiazepines were the most inappropriately prescribed group. Antiplatelet agents and statins are the indicated non-prescription drugs. Conclusions: Polymedicated elderly patients living in the residential environment follow prescriptions of frequently used groups/drugs which are related to prescription errors with exposure to inadequate polypharmacy and pharmacotherapeutic complexity with a possible threat to the quality of life of the institutionalized elderly people(AU)


Subject(s)
Humans , Geriatric Assessment , Polypharmacy , Nonprescription Drugs , Potentially Inappropriate Medication List , Epidemiology, Descriptive , Cross-Sectional Studies , Inappropriate Prescribing
6.
Ciênc. Saúde Colet ; 26(5): 1781-1792, maio 2021. tab
Article in Portuguese | LILACS | ID: biblio-1249491

ABSTRACT

Resumo Os idosos são vulneráveis aos riscos do uso de medicamentos, principalmente daqueles considerados potencialmente inapropriados (MPI) em que os riscos superam os benefícios. O estudo buscou avaliar os MPI prescritos na Atenção Primária à Saúde (APS) e seus fatores associados. Realizou-se um estudo transversal, analítico, de março a dezembro de 2019, na APS em Campina Grande, Paraíba, através de entrevistas com 458 idosos. As variáveis independentes abrangeram características socioeconômicas, condição de saúde e utilização de medicamentos e o desfecho foi medicamento classificado como MPI pelo Consenso Brasileiro de Medicamentos Potencialmente Inapropriados. Verificou-se a prescrição de pelo menos um MPI para 44,8% dos idosos e a maioria de atuação no Sistema Nervoso Central (54,4%). No modelo ajustado, depressão (RP=2,01; IC95% 1,59-2,55), utilizar outros medicamentos além dos prescritos (RP=1,36; IC95% 1,08-1,72) e polifarmácia (RP=1,80; IC95% 1,40-2,33) permaneceram como fator associado e autorreferir ser portador de hipertensão arterial sistêmica tornou-se fator de proteção (RP=0,65; IC95% 0,49-0,87). Evidencia-se necessidade de ações que qualifiquem o uso de medicamentos por idosos, de modo a garantir acesso aliado à segurança.


Abstract The elderly population is vulnerable to the risks of the use of medications, especially those considered potentially inappropriate medications (PIMs), in which the risks outweigh the benefits. The study sought to evaluate the PIMs prescribed in Primary Health Care (PHC) and associated factors. A cross-sectional, analytical study was carried out from March to December 2019 in PHC in Campina Grande, Paraíba, through interviews with 458 elderly individuals. The independent variables included socioeconomic characteristics, health status and the use of medications, and the outcome was classified as PIM by the Brazilian Consensus on Potentially Inappropriate Medications. There was a prescription of at least one PIM for 44.8% of the elderly and the majority affecting the Central Nervous System (54.4%). In the adjusted model, depression (PR=2.01; 95%CI 1.59-2.55), using other medications in addition to those prescribed (PR=1.36; 95%CI 1.08-1.72) and polypharmacy (PR=1.80; 95%CI 1.40-2.33) remained an associated factor, and self-reporting systemic arterial hypertension became a protective factor (PR=0.65; 95%CI 0.49-0.87). This reveals the need for actions to monitor closely the use of PIMs by the elderly to ensure access in conjunction with safety.


Subject(s)
Humans , Aged , Inappropriate Prescribing , Potentially Inappropriate Medication List , Primary Health Care , Brazil , Cross-Sectional Studies , Risk Factors , Polypharmacy , Prescriptions
7.
Säo Paulo med. j ; 139(2): 107-116, Mar.-Apr. 2021. tab
Article in English | LILACS | ID: biblio-1290229

ABSTRACT

ABSTRACT BACKGROUND: Physician and patient-related characteristics can influence prescription of medications to older patients within primary healthcare. Use of Brazilian criteria may indicate the real prevalence of prescription of potentially inappropriate medications to this population. OBJECTIVES: To evaluate prescription of potentially inappropriate medications to older patients within primary care and identify patient-related and prescribing physician-related factors. DESIGN AND SETTING: This cross-sectional study was conducted in 22 public primary care facilities in Brazil, among older people (≥ 60 years) who were waiting for medical consultations. METHODS: Interviews were conducted before and after the medical consultations. If the patient received a medical prescription at the consultation, all the drugs prescribed and the physician's medical council registration number were recorded. Prevalence ratios were estimated to ascertain the magnitude of prescription of potentially inappropriate medications, along with patient and physician-related factors associated with such prescription. RESULTS: In total, 417 older patients were included; 45.3% had received ≥ 1 potentially inappropriate medication, and 86.8% out of 53 physicians involved had prescribed ≥ 1 potentially inappropriate medication. The strongest patient-related factor associated with higher prevalence of prescription of potentially inappropriate medications was polypharmacy. Among physician-related factors, the number of patients attended, number of prescriptions and length of medical practice < 10 years were positively associated with prescription of potentially inappropriate medications. CONCLUSIONS: High prevalence of prescription of potentially inappropriate medications was observed. Physician-related characteristics can influence prescription of medications to older people within primary healthcare. This suggests that there is a need for interventions among all physicians, especially younger physicians.


Subject(s)
Humans , Aged , Physicians , Inappropriate Prescribing , Primary Health Care , Brazil , Cross-Sectional Studies , Polypharmacy
8.
Ciênc. Saúde Colet ; 26(4): 1553-1564, abr. 2021. tab
Article in Portuguese | LILACS | ID: biblio-1285940

ABSTRACT

Resumo O objetivo deste artigo é analisar a prevalência de polifarmácia e de polifarmácia excessiva, bem como seus fatores associados, entre idosos atendidos em duas Unidades Básicas de Saúde de Belo Horizonte-MG. Foi conduzido um estudo observacional transversal, realizado por meio de informações resultantes de uma entrevista estruturada ao paciente. Foram analisadas as associações individuais de cada variável explicativa com a polifarmácia e polifarmácia excessiva. Para as variáveis que apresentaram associação significativa com polifarmácia, foi realizada análise multivariada por meio do modelo de regressão logística. Os idosos utilizavam, em média, 5,2 fármacos. A prevalência de polifarmácia foi de 57,7% e de polifarmácia excessiva foi de 4,8%. Na análise univariada, mostraram-se associadas à polifarmácia as condições idade ≤ 70 anos, escolaridade > 8 anos, presença de mais de três doenças e presença de sintomas de depressão. Para polifarmácia excessiva, mostraram-se associadas as condições presença de mais de três doenças, autopercepção da saúde negativa e dependência parcial nas atividades instrumentais de vida diária. No modelo multivariado final para polifarmácia, permaneceram as variáveis idade ≤ 70 anos e presença de mais de três doenças.


Abstract The scope of this article is to analyze the prevalence of polymedication and excessive polypharmacy, as well as associated factors, among the elderly attended at two Basic Health Units in Belo Horizonte, State of Minas Gerais. A cross-sectional observational study was conducted using information obtained from a structured interview of the patient. The individual associations of each explanatory variable with polypharmacy and with excessive polypharmacy were analyzed. For the variables that showed a significant association with polypharmacy, multivariate analysis was performed using the logistic regression model. The elderly used, on average, 5.2 drugs. The prevalence of polymedication was 57.7% and excessive polypharmacy was 4.8%. In univariate analysis the conditions associated with polypharmacy were: age ≤ 70 years, schooling > 8 years, presence of more than three diseases and presenting symptoms of depression. For excessive polypharmacy, the presence of more than three diseases, self-perception of negative health, and partial dependence on instrumental activities of daily living were associated with the conditions. In the final multivariate model for polypharmacy, the age ≤ 70 years and presence of more than three disease variables remained.


Subject(s)
Humans , Aged , Activities of Daily Living , Polypharmacy , Primary Health Care , Socioeconomic Factors , Brazil/epidemiology , Prevalence , Cross-Sectional Studies
9.
ABCS health sci ; 46: e021212, 09 fev. 2021. tab, ilus
Article in English | LILACS | ID: biblio-1281233

ABSTRACT

INTRODUCTION: Treatment for multiple sclerosis should focus on relapse prevention and treatment, as well as symptom and disease progression control, which require the use of multiple medications. OBJECTIVE: To evaluate the association of polypharmacy and related clinical, epidemiological factors in multiple sclerosis patient cohorts. METHODS: It was conducted a prospective study of multiple sclerosis patients that held a prescription of disease-modifying drugs between January and December 2017. The medications were analyzed and classified as either long-term or as-needed medications for therapeutic objective and prescription status purposes. RESULTS: During 2017, 124 patients were attended, 106 were eligible for the study, and 81 agreed to participate. The average age was 40.95±11.69 years. The disease duration varied between 6 months and 30 years, with a median of 7 years. More than half of the multiple sclerosis patients suffered from comorbidities (54.32%), and 76.54% were categorized as polypharmacy. The comparison of polypharmacy between the groups yielded significant differences for comorbidities and employment status and regarding age between patients with polypharmacy and patients without polypharmacy of long-term medications. CONCLUSION: The age of the patient and the presence of comorbidities are important factors related to polypharmacy.


INTRODUÇÃO: O tratamento da esclerose múltipla deve ser concentrado na prevenção e tratamento de recaídas, bem como no controle da progressão dos sintomas e doenças, o que requer o uso de vários medicamentos. OBJETIVO: Avaliar a associação de polifarmácia a fatores epidemiológicos clínicos em uma coorte de pacientes com esclerose múltipla. MÉTODOS: Foi realizado um estudo prospectivo de pacientes com esclerose múltipla que possuíam prescrição de medicamentos modificadores da doença entre janeiro e dezembro de 2017. Os medicamentos foram analisados e classificados como medicamentos de longo prazo ou conforme necessário para fins terapêuticos de objetivo e status de prescrição. RESULTADOS: Durante 2017 foram atendidos 124 pacientes, destes 106 pacientes foram elegíveis para o estudo e 81 concordaram em participar. A idade média foi de 40,95±11,69 anos. A duração da doença variou entre 6 meses e 30 anos, com mediana de 7 anos. Mais da metade dos pacientes com esclerose múltipla apresentava comorbidades (54,32%) e 76,54% foram classificados com polifarmácia. A comparação da polifarmácia entre os grupos demonstrou diferenças significativas para comorbidades, e situação de trabalho, e em relação à idade entre pacientes com polifarmácia e pacientes sem polifarmácia com medicamentos de longa duração. CONCLUSÃO: A idade do paciente e a presença de comorbidades são fatores importantes relacionados à polifarmácia.


Subject(s)
Humans , Male , Female , Adult , Middle Aged , Aged , Young Adult , Polypharmacy , Multiple Sclerosis/drug therapy , Multiple Sclerosis/epidemiology , Comorbidity , Prospective Studies
10.
Einstein (Säo Paulo) ; 19: eAO5565, 2021. tab
Article in English | LILACS | ID: biblio-1154094

ABSTRACT

ABSTRACT Objective: To determine the factors associated with the high complexity of medication regimen in patients with coronary artery disease. Methods: A cross-sectional study was carried out in a multiprofessional cardiology outpatient clinic, in the Secondary Care of the Unified Health System, where sociodemographic (age, sex, and education), clinical (number of health conditions, cardiovascular diagnoses, and comorbidities) and pharmacotherapeutic (adherence, polypharmacy, and cardiovascular polypharmacy) characteristics were collected. These were related to complexity of medication regimen, measured through the medication regimen complexity index. The classification of high complexity of medication regimen was carried out using standardization for the older adults and stratification for adult patients, as suggested in the literature. Results: The total complexity medication regimen of 148 patients had a median of 17.0 (interquartile range of 10.5). In the univariate analysis, the factors associated with high complexity were heart failure, diabetes mellitus, hypertension, five or more diseases, and non-adherence to treatment. In the final model, after logistic regression, there was a statistically significant association (p<0.05) with the variables diabetes mellitus, hypertension, and non-adherence. Conclusion: The high complexity of medication regimen in patients with coronary artery disease was associated with the presence of diabetes mellitus, hypertension, and reports of non-adherence to treatment.


RESUMO Objetivo: Determinar os fatores associados à complexidade alta da farmacoterapia em pacientes com doença arterial coronariana. Métodos: Realizou-se um estudo transversal em um ambulatório multiprofissional de cardiologia na Atenção Secundária do Sistema Único de Saúde, de onde foram coletadas características sociodemográficas (idade, sexo e escolaridade), clínicas (número de condições de saúde, diagnósticos cardiovasculares e comorbidades) e farmacoterápicas (adesão, polifarmácia e polifarmácia cardiovascular). Essas características foram relacionadas com a complexidade da farmacoterapia, mensurada por meio do Índice de Complexidade da Farmacoterapia. A classificação em complexidade alta da farmacoterapia foi realizada empregando a normatização para idosos e a estratificação para pacientes adultos, sugeridas na literatura. Resultados: A complexidade da farmacoterapia total dos 148 pacientes apresentou mediana igual a 17,0 (amplitude interquartílica de 10,5). Na análise univariada, os fatores associados à complexidade alta foram insuficiência cardíaca, diabetes mellitus, hipertensão arterial, cinco ou mais doenças e não adesão. No modelo final, após regressão logística, houve associação estatisticamente significante (p<0,05) com as variáveis diabetes mellitus, hipertensão arterial e não adesão. Conclusão: A complexidade alta da farmacoterapia em pacientes com doença arterial coronariana foi associada à presença de diabetes mellitus, hipertensão arterial e relato de não adesão a medicamentos


Subject(s)
Humans , Coronary Artery Disease/drug therapy , Polypharmacy , Medication Adherence , Comorbidity , Logistic Models , Cross-Sectional Studies , Diabetes Mellitus , Hypertension
11.
Esc. Anna Nery Rev. Enferm ; 25(4): e20200355, 2021. tab
Article in Portuguese | LILACS, BDENF | ID: biblio-1286368

ABSTRACT

Resumo Objetivo Verificar a associação entre os marcadores de fragilidade e as características sociodemográficas e clínicas em idosos na Atenção Primária à Saúde. Método Pesquisa transversal, realizada com 356 idosos cadastrados em unidades de saúde da família, no Nordeste do Brasil. Os instrumentos de coleta utilizados foram o Índice de Vulnerabilidade Clínico-Funcional e outro de perfil socioeconômico e de saúde. Analisaram-se os dados pela estatística inferencial, utilizando o teste do Qui-quadrado, com nível de significância 0,05. Resultados A média de idade foi de 72,85 anos (±8,965); 63,8% eram do sexo feminino, 39% apresentaram risco de fragilização e 22,5% demonstraram fragilidade. Houve associação entre fragilidade, sexo, faixa etária, estado civil, escolaridade, renda, presença de doença cardíaca e hipertensão. Conclusões e implicações para a prática Os marcadores de fragilidade nos idosos evidenciaram associação entre as características sociodemográficas e clínicas, indicando a necessidade de rastreio precoce no nível primário de atenção à saúde.


Resumen Objetivo Verificar la asociación entre los marcadores de fragilidad y las características sociodemográficas y clínicas en ancianos en Atención Primaria de Salud. Método Investigación transversal realizada con 356 ancianos registrados en unidades de salud familiar en Nordeste de Brasil. Los instrumentos de recolección utilizados fueron el Índice de Vulnerabilidad Clínico-Funcional y otro de perfil socioeconómico y de salud. Los datos se analizaron mediante estadística inferencial utilizando la prueba de Chi-cuadrado, con nivel de significancia de 0.05. Resultados La edad media fue de 72,85 años (± 8,965), el 63,8% eran mujeres, el 39% tenían riesgo de fragilidad y el 22,5% eran frágiles. Hubo asociación entre fragilidad, sexo, edad, estado civil, educación, ingresos, presencia de cardiopatía e hipertensión. Conclusiones e implicaciones para la práctica Los marcadores de fragilidad en ancianos se asociaron con características sociodemográficas y clínicas, lo que indica la necesidad de rastreo precoz en el nivel primario de atención a la salud.


Abstract Objective to verify the association between frailty markers and sociodemographic and clinical characteristics in elderly people in Primary Health Care. Method cross-sectional research, carried out with 356 elderly people registered in family health units in the Northeast of Brazil. The collection instruments used were the Index of Clinical-Functional Vulnerability and another of socioeconomic and health profile. The data were analyzed by inferential statistics, using the chi-square test, with a significance level of 0.05. Results the mean age was 72.85 years (±8.965); 63.8% were female, 39% were at risk of frailty and 22.5% were frail. There was an association between frailty, gender, age group, marital status, education, income, presence of heart disease and hypertension. Conclusions and implications for practice the markers of frailty in the elderly showed an association between sociodemographic and clinical characteristics, indicating the need for early screening at the primary health care level.


Subject(s)
Humans , Male , Female , Aged , Aged, 80 and over , Primary Health Care , Socioeconomic Factors , Health Profile , Epidemiologic Factors , Health of the Elderly , Frailty/epidemiology , Quality of Life , Accidental Falls , Body Mass Index , Chronic Disease , Prevalence , Cross-Sectional Studies , Frail Elderly , Polypharmacy , Depression , Diabetes Mellitus , Health Vulnerability , Sarcopenia , Diagnostic Self Evaluation , Heart Diseases , Hypertension
12.
Rev. bras. educ. méd ; 45(3): e158, 2021. tab, graf
Article in English | LILACS | ID: biblio-1288305

ABSTRACT

Abstract: Introduction: Given the high prevalence of polypharmacy patients, it is paramount that they be handled with an effective therapeutic alliance and with safe and feasible treatments. Empathy towards the patient is essential, and the lack of prescriber experience may hamper such bond. Objectives: This study simulates a polypharmacy regimen among medical students, aiming to promote reflections about the daily challenges faced by patients. Methods: It is a prospective study in a single, non-blind group. The participants were medical students and residents from our institution, all of whom followed a 7-day placebo prescription. They answered questionnaires on their perceptions of medication adherence and concordance before and after the simulation. Results: twenty-eight volunteers participated, 27 of which (96.4%) forgot to take at least one pill during the experiment. Among the lower undergraduates, 28.57% interrupted at least one medication. As for the higher undergraduates and residents, this happened with 71.43% of them. There were more adherence failures than predicted by the participants themselves. In realistic dosages, levothyroxine, angiotensin-converting enzyme inhibitors and metformin were the drugs reported to be the most difficult. 96% of the volunteers strongly agreed that doctor and patient's agreement regarding the treatment correlates with good adherence. Conclusion: Understanding the factors that affect adherence and how to handle them is essential for a doctor, as well as a good bond with the patient. The teaching of these abilities is very necessary. Further studies are needed to reach more undergraduate students and to highlight the relevance of simulations in the medical education setting.


Resumo: Introdução: Com a prevalência de pacientes polimedicados, é essencial que estes sejam manejados com aliança terapêutica efetiva e tratamentos factíveis e seguros. A empatia com o paciente é indispensável, e a falta de experiência dos prescritores pode impedir esse vínculo. Objetivo: O presente estudo simula um regime polimedicamentoso com acadêmicos de Medicina, para promover reflexões sobre as dificuldades vivenciadas pelos pacientes. Método: É estudo prospectivo em grupo único e não cego. Participaram estudantes de Medicina dos semestres 5 a 7, internos e residentes da nossa instituição, que seguiram regime placebo por sete dias. Antes e depois do período, os voluntários responderam a questionários de percepções sobre aderência medicamentosa e concordância terapêutica. Resultado: Participaram 28 voluntários, dos quais 27 (96,4%) esqueceram-se de utilizar pelo menos uma medicação durante o período. Dos graduandos, 28,57% referiram interrupção do uso de pelo menos uma. Do grupo de internos e residentes, essa porcentagem foi de 71,43%. Houve mais perdas de dose do que o previsto pelos participantes. Seguindo posologias realistas, levotiroxina sódica, inibidor de enzima conversora da angiotensina e metformina foram os fármacos referidos como de maior dificuldade. Do total de participantes, 96% afirmaram com veemência que o tratamento acordado entre médico e paciente deve se correlacionar com a boa aderência terapêutica. Conclusão: A compreensão sobre os fatores que influenciam na aderência e em seus manejos é indispensável na capacitação do médico, bem como o bom vínculo entre médico e paciente. O ensino dessas habilidades é necessário. São necessários estudos adicionais, a fim de alcançar mais graduandos e ressaltar a relevância de simulações no ensino médico.


Subject(s)
Humans , Male , Female , Adult , Middle Aged , Patient Simulation , Polypharmacy , Education, Medical , Treatment Adherence and Compliance , Physician-Patient Relations , Prospective Studies , Empathy
14.
Rev. Pesqui. (Univ. Fed. Estado Rio J., Online) ; 13: 349-354, jan.-dez. 2021. tab
Article in English, Portuguese | LILACS, BDENF | ID: biblio-1151263

ABSTRACT

Objetivo: Identificar a prevalência da multimorbidade e polifarmácia em idosos. Métodos: Estudo com 100 idosos de grupos de idosos do Município de Joaçaba-SC. Os dados foram coletados em julho de 2018 por meio de questionário estruturado e apresentados por contagens, percentuais, média e desvio-padrão. Resultados: A idade variou de 60 a 90 anos, com média de 69,3 (±5,47). O sexo feminino prevaleceu com 78,0%. O total de multimorbidade variou de duas a nove condições crônicas, com prevalência de 75,0% de idosos com multimorbidade. As condições crônicas mais referidas foram Hipertensão Arterial, com 76,0% e Diabetes Mellitus, com 46,0%. O uso de medicação continua está presente em 86,0% dos idosos e a prevalência de polifarmácia foi de 18,0%. Conclusão: entre os idosos que possuíam multimorbidade e polifarmácia prevaleceram as mulheres pertencentes à classe econômica mais pobre


Objective: To identify the prevalence of multimorbity and polypharmacy in the elderly Methods: A study with 100 elderly individuals from the elderly population of Joaçaba-SC. Data were collected in July 2018 through a structured questionnaire and presented by counts, percentages, mean and standard deviation. Results: Age ranged from 60 to 90 years, with a mean of 69.3 (± 5.47). The female sex prevailed with 78 (78%). The total multimorbity ranged from two to nine chronic conditions, with a prevalence of 75 (75%) of elderly individuals with multimorbidity. The most frequent chronic conditions were Arterial Hypertension, with 76 (76%) and Diabetes Mellitus, with 46 (46%). The use of continuous medication is present in 86 (86%) of the elderly and the prevalence of polypharmacy was 18 (18%). Conclusion: Among the elderly who had multimorbity and polypharmacy, women belonging to the poorest economic class prevailed


Identificar la prevalencia de la multimorbidity y polifarmacia en ancianos. Métodos: Estudio con 100 ancianos de grupos de ancianos del Municipio de Joaçaba-SC. Los datos fueron recolectados en julio de 2018 por medio de un cuestionario estructurado y presentados por recuentos, porcentajes, media y desviación estándar. Resultados: La edad varía de 60 a 90 años, con una media de 69,3 (± 5,47). El sexo femenino prevaleció con el 78 (78%). El total de multimorbidity varía de dos a nueve condiciones crónicas, con una prevalencia de 75 (75%) ancianos con multimorbidity. Las condiciones crónicas más referidas fueron Hipertensión Arterial, con 76 (76%) y la Diabetes Mellitus, con 46 (46%). El uso de medicación continua está presente en 86 (86%) de los ancianos y la prevalencia de polifarmacia fue de 18 (18%). Conclusión: entre los ancianos que poseía multimoridad y polifarmacia prevalecieron las mujeres pertenecientes a la clase económica más pobre


Subject(s)
Humans , Male , Female , Aged , Aged, 80 and over , Health of the Elderly , Polypharmacy , Multimorbidity , Aging , Geriatric Assessment
15.
Geriatr., Gerontol. Aging (Impr.) ; 14(4): 294-297, 31-12-2020.
Article in English | LILACS | ID: biblio-1151617

ABSTRACT

Prescribing medications involves complex cognitive processes, and mistakes in prescription can cause serious adverse events. Deprescribing is one of the last opportunities to prevent patient harm from the use of drugs that should be avoided, especially among older patients. This viewpoint article aims to discuss the prescription process and some essential concepts, such as polypharmacy, prescription of potentially inappropriate medications, and, particularly, the relevance of deprescribing and its relationship with the appropriate prescription of medications in older people.


A prescrição de medicamentos envolve processos cognitivos complexos e erros na prescrição podem causar eventos adversos graves. A desprescrição é uma das últimas oportunidades de prevenir danos ao paciente decorrentes do uso de medicamentos que devem ser evitados, principalmente entre pacientes mais velhos. Este artigo teve como objetivo discutir o processo de prescrição e alguns conceitos essenciais, como a polifarmácia, a prescrição de medicamentos potencialmente inadequados e, particularmente, a relevância da desprescrição e sua relação com a prescrição adequada de medicamentos em idosos.


Subject(s)
Humans , Polypharmacy , Prescription Drugs/administration & dosage , Deprescriptions , Drug Prescriptions , Pharmaceutical Preparations
16.
Rev. Assoc. Med. Bras. (1992) ; 66(8): 1087-1092, Aug. 2020. tab, graf
Article in English | SES-SP, LILACS, SES-SP | ID: biblio-1136328

ABSTRACT

SUMMARY OBJECTIVE To identify the use of Potentially Inappropriate Medications with imminent risk of Cardiovascular and Cerebrovascular Adverse Events (PIM-CCVAE), in addition to the factors associated with a group of elderly individuals undergoing therapeutic care in a Brazilian public service. METHODS A cross-sectional retrospective study conducted at a secondary level service located in Carapicuíba, SP, Brasil. Only elderly individuals (≥60 years) who were treated in one of the outpatient departments were included. The use of PIM-CCVAE was defined based on the PIM-CCVAEs list. In this research, we used descriptive statistics and logistic regression to identify and track possible predictors of MPI use. All statistical analyses were performed using Stata software version 15.1 (Stata Corporation). RESULTS The sample included 233 elderly individuals, with a mean age of 74.9 (± 9.4) years. Of these, 74.2% used at least one PIM-CCVAE, with an average daily intake of 1.3 (± 1) PIM/elderly. The presence of comorbidities, diseases of the circulatory system, polypharmacy, and low to moderate scores in morbidity and mortality were important factors associated with an increased odds ratio for the consumption of PIM-CCVAE. It is also emphasized that the presence of neurological symptoms proved to be a protective factor for this outcome. CONCLUSION Given the clinical severity and imminent risk of CCVAE in the researched group, preventive measures should be instituted to minimize health problems related to medication in the public network.


RESUMO OBJETIVO Identificar o uso de Medicamentos Potencialmente Inapropriados (MPI) com risco iminente de EAM cardiovascular e cerebrovascular (EAM-CC), além dos fatores associados a um grupo de idosos em vigência terapêutica de um serviço público brasileiro. MÉTODOS Estudo seccional e retrospectivo realizado em um serviço de nível secundário localizado em Carapicuíba, SP, Brasil. Incluíram-se, apenas, idosos (idade ≥60 anos) que foram tratados em um departamento de atendimento ambulatorial. O uso de MPI com risco iminente de EAM-CC foi definido empregando a lista PIM-CCVAEs. Nesta pesquisa, apropriou-se da estatística descritiva e de regressão logística para identificação e rastreio de possíveis preditores de uso de MPI. Todas as análises estatísticas foram realizadas usando o software Stata version 15.1 (Stata Corporation). RESULTADOS Incluíram-se, na casuística, 233 idosos, com média de idade igual a 74,9 (±9,4) anos. Destes, 74,2% faziam uso de pelo menos um MPI com risco de EAM-CC, atingindo uma média de consumo diário igual a 1,3 (± 1) MPI/idoso. Verificou-se que a presença de comorbidades, doenças do aparelho circulatório, polifarmácia e score baixo a moderado em índices de morbimortalidade foram importantes fatores associados ao aumento da razão de chances para o consumo de MPI com risco de EAM-CC. Ressalta-se ainda que a presença de sintomas neurológicos mostrou-se como fator protetor para este desfecho. CONCLUSÃO Dada a gravidade clínica e o risco iminente de EAM-CC do grupo pesquisado, medidas de prevenção devem ser instituídas com o intuito de minimizar os problemas de saúde relacionados à medicação na rede pública.


Subject(s)
Humans , Aged , Aged, 80 and over , Cardiovascular System , Inappropriate Prescribing , Brazil , Cerebrovascular Disorders , Cross-Sectional Studies , Retrospective Studies , Risk Factors , Polypharmacy
17.
Rev. habanera cienc. méd ; 19(4): e2901, tab, graf
Article in Spanish | LILACS, CUMED | ID: biblio-1139180

ABSTRACT

Introducción: El seguimiento farmacoterapéutico favorece el uso efectivo y seguro de los medicamentos, pero en el país se requiere evidencia de su eficiencia para la toma de decisiones sobre su futura implementación. Objetivo: Determinar la eficiencia del seguimiento farmacoterapéutico a adultos mayores polimedicados en una farmacia especial de área del municipio Diez de Octubre de La Habana, Cuba. Material y Métodos: Análisis costo-efectividad, que comparó realizar el seguimiento farmacoterapéutico a domicilio con no hacerlo. Se utilizó la perspectiva social para estimar el costo por resultado negativo asociado a la medicación resuelto. Se estimó el costo directo de brindar el servicio, así como el impacto económico sobre el consumo de medicamentos y el uso de los servicios de salud por los pacientes. Resultados: En ambos grupos, los pacientes fueron en su mayoría mujeres, la edad media fue de aproximadamente 75 años y 2,02 resultados negativos de la medicación, como promedio. Se resolvieron 27 de los mismos (42,19 por ciento) lo que generó una reducción en el costo por tratamiento farmacológico mensual de 65,45 moneda nacional y por uso de servicios de salud de 465,07 Moneda nacional. El seguimiento farmacoterapéutico resultó una alternativa costo ahorradora, con una liberación de 22,71 Moneda nacional por cada resultado negativo asociados a la medicación resuelto. Conclusiones: El seguimiento farmacoterapéutico comunitario brindado a los adultos mayores polimedicados en un área de salud en La Habana, resultó ser una tecnología eficiente para la racionalización de la terapéutica(AU)


Introduction: Pharmacotherapy follow-up encourages the effective and safe use of medicines; however, evidence of their efficiency is required to make decisions about their future implementation in the country. Objective: To determine the efficiency of the pharmacotherapy follow-up of polymedicated elderly people in Diez de Octubre municipality, Havana, Cuba. Material and Methods: Cost-effectiveness analysis based on the comparison between pharmacotherapy follow-up of medicines administered at home and pharmacotherapy without follow-up. Social perspective was used to estimate the cost of a negative outcome associated with medication. The direct cost of providing the service was estimated, as well as the economic impact on the consumption of medicines and the use of health services by patients. Results: The patients were mostly women in both groups; the mean age was approximately 75 years and there were 2.02 negative outcomes associated with medication, on average. Twenty-seven of them (42.19 percent were resolved, resulting in a reduction in the cost of monthly pharmacological treatment of 65.45 Cuban pesos and a reduction in the health care costs of 465.07 Cuban pesos. Pharmacotherapy follow-up proved to be a cost-saving alternative with a release of 22.71 Cuban pesos for every negative outcome associated with the use of medication. Conclusions: Pharmacotherapy follow-up provided to polymedicated elderly people in a health area in Havana demonstrated to be an efficient technology for the rationalization of therapeutics(AU)


Subject(s)
Humans , Male , Female , Aged , Aged, 80 and over , Cost-Benefit Analysis , Polypharmacy , Drug Utilization , Prescription Drug Misuse , Follow-Up Studies , Cuba
18.
Säo Paulo med. j ; 138(3): 216-218, May-June 2020. tab, graf
Article in English | SES-SP, LILACS, SES-SP | ID: biblio-1139694

ABSTRACT

ABSTRACT BACKGROUND: Improving knowledge and establishing strategies and policies for better patient safety are worldwide priorities. OBJECTIVE: To evaluate drug safety among elderly people with Alzheimer's disease (AD). DESIGN AND SETTING: Cross-sectional study among elderly people within the National AD Assistance Protocol (PCDTDA/MS) who were living in the municipality of Araraquara, Brazil, in 2017. METHODS: Through interviews conducted with relatives/caregivers of elderly people with diagnoses of AD, the following variables were evaluated: comorbidities, drug therapy used, use of potentially inappropriate medications for the elderly (PIMs), presence of potentially inappropriate interactions (PIIs) and medication regimen complexity index. Factors associated with AD severity were also evaluated. Multivariate and simple logistic regressions were applied. RESULTS: 143 elderly people enrolled in PCDTDA/MS were analyzed. The majority were women (67.1%); assisted only through the public healthcare system (75.5%); polymedicated (57.4%); using at least one PIM (63.6%); presenting at least one PII (63.6%); and under drug therapy of low to medium complexity (92.2%). No semi-annual monitoring of the effectiveness of PCDTDA/MS drugs was identified. The proportion using AD drug therapy at daily doses differing from those recommended by the World Health Organization was 75.6%. However, these doses were not associated with drug risk. CONCLUSION: The data from this study raise the hypothesis that use of polypharmacy might show a correlation with severity of AD. The drug safety risk may be associated with comorbidities of the metabolic syndrome, anxiety and off-label use of PIMs, such as risperidone and quetiapine, and benzodiazepines (i.e. clonazepam and flunitrazepam).


Subject(s)
Humans , Male , Female , Aged , Alzheimer Disease/drug therapy , Brazil , Cross-Sectional Studies , Risk Factors , Polypharmacy , Inappropriate Prescribing
19.
Säo Paulo med. j ; 138(3): 235-243, May-June 2020. tab, graf
Article in English | SES-SP, LILACS, SES-SP | ID: biblio-1139693

ABSTRACT

ABSTRACT BACKGROUND: Access to medicines is an important indicator of healthcare system quality and capacity to resolve problems. The healthcare system needs to ensure free access to medicines for elderly people, in order to provide greater effectiveness of disease control, thus reducing morbidity and mortality, and improving health and quality of life. OBJECTIVES: To analyze the frequency of free access to medication among older adults within primary care and determine the factors associated with free access. DESIGN AND SETTING: Cross-sectional study at two primary care units. METHODS: Free access was defined as provision of all medicines through pharmacies within the Brazilian National Health System and through the Brazilian program for free medicines in private pharmacies. We investigated the sociodemographic, clinical, functional and pharmacotherapeutic characteristics of older adults. Multivariate logistic regression was performed to identify factors associated with free access to medicines. RESULTS: This study included 227 older adults, among whom 91 (40.1%) had free full access to prescription drugs. A direct association with age ≤ 70 years and indirect associations with polypharmacy and multimorbidity (P < 0.05) were found. CONCLUSIONS: Age ≤ 70 years increases the likelihood of having free full access to medicines, and older adults with multimorbidity and polypharmacy use have a lower likelihood of access. Identification of factors associated with free access to medicines among elderly people provides elements to guide the Brazilian National Health System in implementing access improvement actions.


Subject(s)
Humans , Aged , Quality of Life , Primary Health Care , Brazil , Cross-Sectional Studies , Polypharmacy , Health Services Accessibility
20.
Archiv. med. fam. gen. (En línea) ; 17(1): 26-34, mayo 2020. tablas
Article in Spanish | LILACS, InstitutionalDB, BINACIS, UNISALUD | ID: biblio-1342880

ABSTRACT

Los adultos mayores (AM) presentan multimorbilidad y son vulnerables a las consecuencias de la polifarmacia, incluyendo las prescripciones potencialmente inadecuadas (PPI). El objetivo del estudio fue caracteri-zar a un grupo de AM de un centro de atención primaria de Chile, conocer su terapia farmacológica y pesquisar posibles interacciones medicamentosas. Se realizó un estudio transversal que incluyó a AM del programa Más AM Autovalentes. Se aplicaron instrumentos de recolección de datos y se revisaron sus fichas clínicas, describiendo sus condiciones socioeconómicas, clínicas y uso de medicamentos. Para detectar PPI se aplicaron los criterios de Beers. Se incluyeron 18 AM (94% mujeres), la mayoría con un bajo nivel socioeconómico. Las principales enfermedades crónicas fueron cardiovasculares y endocrino-metabólicas. El 66,7% presentó polifarmacia. Las PPI se relacionaron principalmente a fármacos antidepresivos, antipsicóticos y antiinflamatorios. Las PPI se asocian especialmente a comorbilidades de patologías crónicas, lo que hace necesario monitorizar permanentemente la respuesta de los AM a la terapia administrada (AU)


Older adults (OA) exhibit multimorbidity and are vulnerable to the consequences of polypharmacy, including potentially inappropriate prescriptions (PIP). The aim of the study was to characterize a group of older adults attending a public primary health center in Chile, examine their drug therapy and detect possible PIP. We conducted a descriptive cross-sectional study, including the OA attending the More Autonomous OA Program. Data collecting instruments were applied and the clinical records were revised, describing their socio-economic and clinical conditions and the use of medicines. To detect PIP the Beers' criteria were applied. Eighteen OA (94% women) were included, most of them with low socio-economic level. The main chronic diseases were cardiovascular and endocrine-metabolic; 66.7% presented polypharmacy and PIP were mainly related to the use of antidepressants, antipsychotics and anti-inflammatory drugs. PIP are associated to the comorbidities of chronic diseases, which makes it mandatory to monitor constantly the response of OA to the administered therapy (AU)


Subject(s)
Humans , Male , Female , Middle Aged , Aged , Aged, 80 and over , Polypharmacy , Drug Interactions , Chile , Inappropriate Prescribing
SELECTION OF CITATIONS
SEARCH DETAIL